JPMorgan U.S. Research Enhanced Equity Fund Class R6 JDEUX

Despite tight constraints, an experienced portfolio manager and J.P. Morgan’s analytical firepower supporting a well-designed approach give JPMorgan US Research Enhanced Equity an edge. We maintain an Above Average People rating and upgrade the Process Pillar to Above Average from Average, reflecting confidence in the research-enhanced index framework’s ability to deliver modest, but repeatable, excess returns. This is particularly relevant in the US large blend equity Morningstar Category, where many less constrained peers have struggled to generate reliable outperformance, making the strategy’s measured, research-driven approach a sensible and competitive alternative.

The strategy is part of J.P. Morgan’s broader Research Enhanced Index platform. The platform comprises seven portfolio managers with long tenures and deep familiarity with J.P. Morgan’s systematic, research-driven framework. Raffaele Zingone has led the US Research Enhanced strategy since November 2016 and brings more than three decades of experience at J.P. Morgan. While he oversees portfolio construction and risk management, stock selection is driven by the firm’s central US equity analyst team, one of the strongest in the industry. Turnover on the team has been an issue in the past, but stability has improved since 2024. Analyst incentives remain closely tied to stock selection outcomes, aligning interests with investors.

The strategy blends elements of index and quantitative active investing, expressing analyst insights through small-stock level over- and underweights while keeping sector, style, and factor exposures close to those of the S&P 500. Operating under a tight tracking error budget of around 1.5%, the portfolio remains broadly diversified, typically holding around 150 stocks with an active share in the 30% to 40% range.

Performance has been consistent with expectations for a low-tracking-error enhanced-indexing strategy. Over longer horizons, the strategy has delivered modest, incremental outperformance versus its benchmark and category peers, despite some recent headwinds in a narrowly led, momentum-driven market environment. Risk has remained well controlled, and the strategy continues to benefit from fees that tend to be meaningfully lower than those of most fully active peers.

The Process Pillar rating is upgraded to Above Average from Average, reflecting a disciplined and repeatable approach that effectively leverages J.P. Morgan’s analytical capabilities while tightly controlling risk.

The approach combines elements of index and quantitative active investing, incorporating the fundamental research insights of J.P. Morgan’s analyst teams to enhance returns relative to a passive exposure while keeping risks in check. Analyst insights are expressed through small-stock level overweight and underweight positions, while aiming to maintain neutrality at the region, sector, and style levels.

The fundamental research process focuses on identifying companies with durable competitive advantages, attractive growth prospects, and identifiable catalysts for change. To guide analysis, the analyst teams apply a strategic classification framework, categorizing companies as Premium, Quality, Standard, or Challenged based on their economics, duration of value creation, and corporate governance characteristics. Analysts then produce long-term valuation forecasts derived from an in-house dividend discount model incorporating earnings, cash flow, and growth assumptions, and rank stocks within each industry based on estimated fair value.

The portfolio manager constructs the portfolio using an optimizer that reflects analyst rankings while operating within tight portfolio constraints. Turnover is managed deliberately and typically ranges between 20% and 40% annually.

The portfolio remains closely aligned with the S&P 500 across sector, style, and beta dimensions, reflecting its tight-tracking error budget of roughly 150 basis points, which limits the scope for active positioning. Individual holdings are expressed through small deviations from benchmark weights, with the largest over- and underweights typically at around plus/minus 80 basis points relative to the index, though many positions tend to stay considerably closer to benchmark levels.

The strategy typically holds around 150 stocks. Active share relative to the S&P 500 tends to be modest, generally in the 30% to 40% range. The portfolio is rebalanced regularly to reflect updated analyst views and valuation signals while operating within clearly defined risk constraints. This disciplined approach reinforces the strategy’s role as a core US large-cap equity allocation, aiming to deliver incremental excess returns without materially altering the portfolio’s overall market profile.

An experienced portfolio manager and the firm’s analytical firepower support an Above Average People rating.

Raffaele Zingone had served as a comanager here since 2002 before taking over lead manager duties in November 2016. He brings more than three decades of experience at J.P. Morgan, having joined the firm in 1991. Comanager Tim Snyder was promoted to the role in 2016 after serving as an analyst at the firm for more than a decade, but he isn't involved in day-to-day portfolio management. Stock selection is driven by J.P. Morgan’s central equity analyst team, with Zingone focused primarily on portfolio construction and risk management.

The strategy is part of J.P. Morgan’s broader Research Enhanced Index platform, led by Piera Elisa Grassi. The platform comprises seven portfolio managers with long tenures and deep familiarity with J.P. Morgan’s systematic, research-driven framework.

The strategy's analyst-driven approach means the firm’s 20-person US fundamental equity team plays a key role. Analysts cover the S&P 500 using a consistently applied fundamental framework and benefit from strong access to company management. Compensation structures closely link analyst pay to the performance of their stock recommendations, reinforcing alignment with shareholders. Following a period of elevated turnover earlier in the decade, team stability has improved since 2024.

Global REI team members' compensation is linked to both alpha and risk, emphasizing the importance of risk management for these strategies. They are also invested in the REI strategies, aligning with investor interest.

J.P. Morgan continues to build a track record of strong stewardship, supporting a Parent rating upgrade to High from Above Average.

With more than USD 4 trillion in assets under management (including USD 1.3 trillion in money market funds) and a broad reach, J.P. Morgan is among the largest active asset managers in the US, Europe, and Asia. Although some multi-asset offerings have struggled over the past five years, prompting new leadership to make changes to investment teams, its equity and fixed-income teams boast long-tenured portfolio managers who practice repeatable investment processes that have generally produced strong long-term results. Most of its funds are core building blocks with long lifetimes, though its lineup around the world also includes more-specialized options: Two options-based equity-income exchange-traded funds, launched in 2020 and 2022, are now among the firm’s largest. J.P. Morgan has been an early mover in offering active ETFs, having converted 12 of its open-end mutual funds to the structure and launching others. It isn’t always at the forefront of emerging trends. While it has filed registration statements with the Securities and Exchange Commission for an interval fund and an ETF investing in private markets, it hasn’t yet introduced such an option for all investors, whether on its own or in partnership with another asset manager, unlike some of its closest competitors.

To support the firm’s diverse investment offerings, J.P. Morgan has invested heavily in both portfolio management tools and its client organization. Over the past 10 years, the firm has developed robust proprietary technology with advanced analytics and broad buy-in from investment analysts, portfolio traders, and portfolio managers, all of whom have easy access to the platform. The firm also stands apart for its demonstrated commitment to clients. In the early 2000s, J.P. Morgan began pivoting its engagement with financial advisors to adopt a more consultative approach, supported by its sought-after Guide to the Markets research series that focuses on investor education, not product pitches. This perspective can help clients stay the course, supporting positive investor outcomes.

Incentives reinforce alignment with fundholders. Beginning more than 10 years ago, investment team compensation is tied to three-, five-, and 10-year performance, and portfolio managers must invest at least half of their deferred compensation in J.P. Morgan strategies. Many firms encourage portfolio managers to invest alongside fundholders, but J.P. Morgan goes a step further in requiring client-facing individuals to invest substantial portions of their incentive compensation in the funds.

Although some funds still face high cost hurdles, more than half of share classes charge competitive fees relative to peers.

Performance has been in line with expectations for a low-tracking-error enhanced-indexing strategy. Since taking its current form in November 2016, the strategy has delivered modest, steady outperformance relative to its benchmark and more pronounced excess returns relative to category peers, with tracking error remaining well within the 150-basis-point limit and stock-picking driving relative returns. Realized tracking error over the last five years through March 2026 has been 0.91%.

Short-term results have softened since late 2024, as market leadership compressed into a narrow cohort of high beta and richly valued stocks, creating a challenging environment for the strategy’s valuation-anchored approach. The team also underestimated the pace of earnings upgrades among a narrow group of artificial intelligence-exposed companies, leaving the portfolio underexposed to several outsize winners such as Palantir. Mixed outcomes among the Magnificent Seven further detracted, alongside weakness in healthcare led by UnitedHealth. Several positions where the team believes they were early and increased exposure, including AJ Gallagher, Stryker, ServiceNow, and EOG, also weighed on relative results.

JPMorgan US Research Enhanced Equity R6's Prospectus Adjusted Expense Ratio is 0.25% per year. It places it in the cheapest quintile of the Morningstar US Fund Large Blend Category, where the median fee is 0.67% per year. This cost positioning translates into a Medalist Rating Price Score of 1.6, which reflects its relative price positioning within the category. The Price Score ranges from -2.50 (most expensive) to +2.50 (cheapest), with higher scores indicating better cost competitiveness.